Literature DB >> 9501277

In vivo NMR spectroscopy in patients with phenylketonuria: clinical significance of interindividual differences in brain phenylalanine concentrations.

J Weglage1, H E Möller, D Wiedermann, S Cipcic-Schmidt, J Zschocke, K Ullrich.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9501277     DOI： 10.1023/a:1005327801588

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN： 0141-8955            Impact factor:   4.982


× No keyword cloud information.
  8 in total

1.  Adult-onset phenylketonuria revealed by acute reversible dementia, prosopagnosia and parkinsonism.

Authors:  Francesca Rosini; Alessandra Rufa; Lucia Monti; Letizia Tirelli; Antonio Federico
Journal:  J Neurol       Date:  2014-10-31       Impact factor: 4.849

2.  Brain phenylalanine concentration in the management of adults with phenylketonuria.

Authors:  R A Moats; R Koch; K Moseley; P Guldberg; F Guttler; R G Boles; M D Nelson
Journal:  J Inherit Metab Dis       Date:  2000-02       Impact factor: 4.982

3.  Phenylketonuria: brain phenylalanine concentrations relate inversely to cerebral protein synthesis.

Authors:  Martijn J de Groot; Paul E Sijens; Dirk-Jan Reijngoud; Anne M Paans; Francjan J van Spronsen
Journal:  J Cereb Blood Flow Metab       Date:  2014-10-29       Impact factor: 6.200

Review 4.  What we know that could influence future treatment of phenylketonuria.

Authors:  C N Sarkissian; A Gámez; C R Scriver
Journal:  J Inherit Metab Dis       Date:  2008-08-03       Impact factor: 4.982

5.  Subclinical visual impairment in phenylketonuria. A neurophysiological study (VEP-P) with clinical, biochemical, and neuroradiological (MRI) correlations.

Authors:  V Leuzzi; S Rinalduzzi; F Chiarotti; P Garzia; G Trasimeni; N Accornero
Journal:  J Inherit Metab Dis       Date:  1998-06       Impact factor: 4.982

6.  Can untreated PKU patients escape from intellectual disability? A systematic review.

Authors:  Danique van Vliet; Annemiek M J van Wegberg; Kirsten Ahring; Miroslaw Bik-Multanowski; Nenad Blau; Fatma D Bulut; Kari Casas; Bozena Didycz; Maja Djordjevic; Antonio Federico; François Feillet; Maria Gizewska; Gwendolyn Gramer; Jozef L Hertecant; Carla E M Hollak; Jens V Jørgensen; Daniela Karall; Yuval Landau; Vincenzo Leuzzi; Per Mathisen; Kathryn Moseley; Neslihan Ö Mungan; Francesca Nardecchia; Katrin Õunap; Kimberly K Powell; Radha Ramachandran; Frank Rutsch; Aria Setoodeh; Maja Stojiljkovic; Fritz K Trefz; Natalia Usurelu; Callum Wilson; Clara D van Karnebeek; William B Hanley; Francjan J van Spronsen
Journal:  Orphanet J Rare Dis       Date:  2018-08-29       Impact factor: 4.123

7.  Untreated PKU Patients without Intellectual Disability: What Do They Teach Us?

Authors:  Danique van Vliet; Annemiek M J van Wegberg; Kirsten Ahring; Miroslaw Bik-Multanowski; Kari Casas; Bozena Didycz; Maja Djordjevic; Jozef L Hertecant; Vincenzo Leuzzi; Per Mathisen; Francesca Nardecchia; Kimberly K Powell; Frank Rutsch; Maja Stojiljkovic; Fritz K Trefz; Natalia Usurelu; Callum Wilson; Clara D van Karnebeek; William B Hanley; Francjan J van Spronsen
Journal:  Nutrients       Date:  2019-10-25       Impact factor: 5.717

Review 8.  A Microbial Community Ecology Perspective on the Gut-Microbiome-Brain Axis.

Authors:  Els van der Goot; Francjan J van Spronsen; Joana Falcão Salles; Eddy A van der Zee
Journal:  Front Endocrinol (Lausanne)       Date:  2020-09-02       Impact factor: 5.555
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.